SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 221 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $57,000 | -16.2% | 6,350 | 0.0% | 0.03% | -15.2% |
Q2 2019 | $68,000 | +11.5% | 6,350 | 0.0% | 0.03% | +6.5% |
Q1 2019 | $61,000 | -22.8% | 6,350 | -7.3% | 0.03% | -32.6% |
Q4 2018 | $79,000 | -40.6% | 6,850 | -12.7% | 0.05% | -16.4% |
Q3 2018 | $133,000 | +19.8% | 7,850 | 0.0% | 0.06% | +14.6% |
Q2 2018 | $111,000 | -25.5% | 7,850 | 0.0% | 0.05% | -27.3% |
Q1 2018 | $149,000 | – | 7,850 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |